PPH

Fund Description
The Market Vectors Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR). The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.
Fund Profile
Fund Name VanEck Vectors Pharmaceutical ETF
Fund Exchange Ticker PPH
Fund Sponsor Van Eck Associates Corporation
Fund ISIN US92189F6925
Net Expense Ratio 0.35 %
Fund Inception Date 20 December 2011
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Market Vectors US Listed Pharmaceutical 25 Index
Index Provider Market Vectors
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Not Applicable
Key Statistics
Return As of Date 22 March 2019
Asset Under Management 189.95 Million (USD)
1 Month Total Return 1.10 %
Year To Date Return 10.46 %
1 Year Total Return 6.89 %
3 Year Annualized Total Return 4.01 %
NAV 60.53
Share Outstanding 3,138,140
Top 10 Holdings (22 March 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
NOVARTIS AG-REG NOVN EQUI 0.051
NOVO NORDISK A/S-B NOVOB EQUI 0.0506
GLAXOSMITHKLINE PLC-SPON ADR GSK EQUI 0.0503
ABBVIE INC ABBV EQUI 0.0501
SANOFI SAN EQUI 0.0501
MERCK & CO. INC. MRK EQUI 0.05
ASTRAZENECA PLC-SPONS ADR AZN EQUI 0.0497
ELI LILLY & CO LLY EQUI 0.0496
PFIZER INC PFE EQUI 0.049
JOHNSON & JOHNSON JNJ EQUI 0.0483